CwDzTKWk
type: Answer
type: WrittenAnswer
answer has question: f6THa7YE
answer has answering person: 42UyXYQP
answer text: Value-based pricing will focus primarily on new medicines. It is possible that a. small number of existing drugs, such as some cancer drugs previously considered but not recommended by the National Institute for Health and Care Excellence (NICE), could be assessed under value-based pricing. However, it is not our intention under value-based pricing to routinely reassess treatments already appraised by NICE.
answer given date: 2013-09-05+01:00
answer has answering body: qjSEa2Ms
written answer has answering body: qjSEa2Ms